InvestorsHub Logo
icon url

weedisgreen

03/02/22 6:36 PM

#69384 RE: player1234 #69383

"Credit facility terms improved including maturity extension to December 2022
~$450 million of cash on balance sheet & improving cashflow positions company to drive sustainable, long-term revenue growth"
icon url

weedisgreen

03/02/22 6:40 PM

#69385 RE: player1234 #69383

I don't have a problem doing your google search.

"So let's begin with a few key highlights. We have one of the strongest balance sheets among Canadian LPs, including approximately $445 million in cash as of yesterday, no term debt and access to a USD 1 billion shelf perspective. This prospectus includes a USD 300 million ATM, from which we have recently drawn down nearly USD 90 million, meant to position us to take advantage of strategic M&A opportunities in the future. Our cash flow continues to improve with $20.3 million used in operating working capital in Q2 compared to $67.3 million in the same period of last year."
icon url

weedisgreen

03/02/22 6:55 PM

#69386 RE: player1234 #69383

O geez. I didn't have the name of the person. Here it is for you. Awesome I can help on this clarification!

Aurora Cannabis, the Canadian company defining the future of cannabinoids worldwide, announced its financial and operational results for the second quarter fiscal 2022 ended December 31, 2021. "During the second quarter, we improved our Adjusted EBITDA by $2.5 million over Q1, moving us closer to our profitability goal. Our focus remains on further cost reductions, and we are pleased to announce today that we expect to reach the high end of the $60 to $80 million range. Our balance sheet remains among the strongest in the industry, with approximately $445 million in cash as of yesterday. This gives us significant working capital to support organic growth and positions us to pursue strategic M&A opportunities," stated Miguel Martin, Chief Executive Officer of Aurora.